Durable, ongoing near-complete response to nivolimab + relatlimab in a 64-year-old with locally-advanced BCC after resistance to 26 weeks of nivolimab alone. Photo by: Evan Lipson, M.D. A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in treatment. Results from the phase 2 clinical trial (NCT03521830), presented Oct. 20 at the European Society

Counties in Pennsylvania near cultivated croplands had significantly higher melanoma rates compared to areas not near farmlands.

Yu-Ying He, PhD. Photo courtesy the University of Chicago In a new study published in Nature Communications , researchers at the University of Chicago have discovered how prolonged exposure to ultraviolet (UV) radiation can trigger inflammation in skin cells by degrading a key protein called YTHDF2. This protein acts as a gatekeeper in preventing normal skin cells from becoming cancerous. The finding reveals that YTHDF2 plays a crucial role in regulating RNA metabolism to mai

Researchers at the Huntsman Cancer Institute at the University of Utah report that individuals with multiple tattoos appear to have a...

Dr. Lee Wheless, photo courtesy Vanderbilt University Medical Centre Dermatologists have recommended the dietary supplement nicotinamide...

Skin cancer risk may be associated with higher levels of serum 25(OH)D.

Dr. Antoni Ribas, senior author of the study and director of the UCLA Health Jonsson Comprehensive Cancer Center’s Tumour Immunology...

The newly designed ExoPatch, being removed from a sample of mouse skin, successfully distinguished melanoma from healthy skin in mice. A...